Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The cardia study

American Journal of Epidemiology

Volumn 148, Issue 9, 1998, Pages 859-868

  Howard, Barbara V ^a   Gidding, Samuel S ^b   Liu, Kiang ^b  

^a Medlantic Research Institute   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apolipoproteins E; Blacks; Cardiovascular diseases; Lipoprotein(a); Men; Whites; Women

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY RISK; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; HYPERLIPIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEGRO; PHENOTYPE; RISK ASSESSMENT;

EID: 0032213544     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009711     Document Type: Article

References (55)

1. Hixson JE, PDAY Research Group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 1991;11:1237-44.
2. Luc G, Bard J-M, Arveiler D, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1994;14: 1412-19.
3. Tiret L, deKnijff P, Menzel H-J, et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European countries. The EARS Study. Arterioscler Thromb 1994;14:1617-24.
4. Utermann G, Langenbeck U, Beisiegel U, et al. Genetics of the apolipoprotein E system in man. Am J Hum Genet 1980; 32:339-47.
5. Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 1981;20:1033-41.
6. Kaprio J, Ferrell RE, Kottke BA, et al. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991;11:1330-48.
7. Xhignesse M, Lussier-Cacan S, Sing CF, et al. Influences of common variants of apoliprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-10.
8. Reilly SL, Ferrell RE, Kottke BA, et al. The sex-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991;49:1155-66.
9. Miettinen TA, Gylling H, Vanhanen H, et al. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 1992;12:1044-52.
10. Miettinen TA. Impact of apo E phenotype on the regulation of cholesterol metabolism. Ann Med 1991;23:181-6.
11. Gerdes LU, Klausen IC, Sihm I, et al. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-67.
12. Ehnholm C, Lukka M, Kuusi T, et al. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. Lipid Res 1986;27: 227-35.
13. Eto M, Watanabe K, Ishii K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin Genet 1986;30:422-7.
14. Evans AE, Zhang W, Moreel JF, et al. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum Genet 1993;92: 191-7.
15. Asakawa J, Takahashi N, Rosenblum BB, et al. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 1985;70:222-30.
16. Wang KQ, He JL, Xie YH. Studies on human apolipoprotein E genetic isoforms and their phenotypes among the Chinese population. Proc Chin Acad Med Sci Peking Union Med Coll 1987;2:133-9.
17. Kao J-T, Tsai K-S, Chang C-J, et al. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995; 114:55-9.
18. Kataoka S, Robbins DC, Cowan LD, et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes: the Strong Heart Study. Arterioscler Thromb Vase Biol 1996;16:918-25.
19. De Knijff P, Johansen LG, Rosseneu M, et al. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 1992;12:1371-9.
20. Sandholzer C, Delport R, Varmaak H, et al. High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet 1995;95:46-8.
21. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-49.
22. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
23. Hughes GH, Cutter GR, Donahue R, et al. Recruitment in the coronary artery disease risk development in young adults (CARDIA) study. Control Clin Trials 1987;8(suppl):68S-73S.
24. Cutter GR, Burke GL, Dyer AR, et al. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 1991;12:1S-77S.
25. Kirkendall WM, Feinleib M, Freis ED, et al. American Heart Association recommendations for human blood pressure determination by sphygmomanometer. Circulation 1980;62: 1146A-55A.
26. Dyer AR, Cutter GR, Liu K, et al. Alcohol intake and blood pressure in young adults: the CARDIA Study. J Clin Epidemiol 1990;43:1-13.
27. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 1986;129:101-23.
28. + + precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
29. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
30. Albers JJ, Aldolphson JL. Comparison of commercial kits for apoprotein A-1 and apoprotein B with standardized apoprotein A-1 and B radioimmunoassays performed at the Northwest Lipid Research Center. J Lipid Res 1988;29:102-8.
31. Albers JJ, Cabana VG, Hazzard WR. Immunoassay of human plasma apolipoprotein B. Metabolism 1975;24:1339-51.
32. Howard BV, Le NA, Belcher JD, et al. Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol 1994;4:341-50.
33. Kamboh MI, Ferrell RE, Kote B. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 1988;29:1535-43.
34. Kataoka S, Paidi M, Howard BV. Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype. Clin Chem 1994;40:11-13.
35. Schaefer EJ, Lamon-Fava S, Johnson S, et al. Effects of sender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1994;14:1105-13.
36. Mahley RW, Palaoglu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36: 839-59.
37. Srinivasan SR, Ehnholm C, Wattigney W, et al. Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: the Bogalusa Heart Study. Metab Clin Exp 1993;42:381-6.
38. Al-Haideri M, Presley JF, Maxfield FR, et al. Apoprotein E4 vs E3: differences in triglyceride-rich particle cell metabolism. In: Council on Arteriosclerosis, American Heart Association, Dallas, TX: abstracts submitted to the Council on Arteriosclerosis for the 68th Scientific Sessions of the American Heart Association, November 13-16, 1995, Anaheim Convention Center, Anaheim, California, 1995:45.
39. Wilson HM, Patel JC, Russell D, et al. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 1993;220:175-87.
40. Ikewaki K Rader DJ, Zech LA, et al. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. J Lipid Res 1994;35:1809-19.
41. Martin LJ, Connelly PW, Nancoo D, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993;34:437-46.
42. Kinoshita M, Arai H, Fukasawa M, et al. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J Lipid Res 1993;34:261-8.
43. Fielding CJ. Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J 1992;6:3162-8.
44. Saxena U, Ferguson E, Bisgaier CL. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. J Biol Chem 1993;268: 14812-19.
45. Wilson PW, Myers RH, Larson MG, et al. Apolipoprotein E alleles dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-71.
46. Valdez R, Howard BV, Stern MP, et al. Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 1995;18:992-1000.
47. Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995;112:145-59.
48. Parra H-J, Luyeye I, Bouramoue C, et al. Black-white differences in serum Lp(a) lipoprotein levels. Clin Chim Acta 1987;167:27-31.
49. Sandholzer C, Hallman DM, Saha N, et al. Effects of apolipoprotein(a) size polymorphism on the lipoprotein(a) concentrations in seven ethnic groups. Hum Genet 1991;86:607-14.
50. Routi T, Ronnemaa T, Salo P, et al. Effects of prospective randomized cholesterol-lowering dietary intervention and apolipoprotein E phenotype on serum lipoprotein(a) concentrations of infants aged 7-24 mo. Am J Clin Nutr 1996;63: 386-91.
51. Horita K, Eto M, Saito M, et al. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. Artery 1993; 20:324-36.
52. Muros M, Rodriguez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins, and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis 1996;121:13-21.
53. Bailleul S, Couderc R, Rossignol C, et al. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin Chem 1995;41:241-5.
54. Heng CK, Saha N, Tay JS. Lack of association of apolipoprotein E polymorphism with plasma Lp(a) levels in the Chinese. Clin Genet 1995;48:113-19.
55. Klausen IC, Gerdes LU, Hansen PS, et al. Effects of apoE gene polymorphism on Lp(a) concentrations depend on the size of apo(a): a study of 466 white men. J Mol Med 1996; 74:685-90.